MDGL FY 2014 Earnings — Madrigal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MDGLMadrigal Pharmaceuticals, Inc.

$10B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$673,000

Operating Income

-$84M

Net Income

-$86M

EPS (Diluted)

$-30.62

Cash Flow

Operating Cash Flow

-$79M

Free Cash Flow

-$79M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$101M

Total Liabilities

$36M

Stockholders' Equity

$65M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$673,000	-$516,000	-30.4%
Operating Income	-$84M	-$88M	+4.1%
Net Income	-$86M	-$90M	+4.5%